Cited by 3,162Lipoproteins and Cardiovascular HealthCardiovascular Health and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Open access

Gordon, D J, Probstfield, J L, Garrison, R J, Neaton, J D, Castelli, W P, Knoke, J D, Jacobs, D R, Bangdiwala, S, Tyroler, H A·1989·Circulation

DOI 10.1161/01.cir.79.1.8

Open this paper in CoChat — free account Open PDF

Abstract

The British Regional Heart Study (BRHS) reported in 1986 that much of the inverse relation of high-density lipoprotein cholesterol (HDLC) and incidence of coronary heart disease was eliminated by covariance adjustment. Using the proportional hazards model and adjusting for age, blood pressure, smoking, body mass index, and low-density lipoprotein cholesterol, we analyzed this relation separately in the Framingham Heart Study (FHS), Lipid Research Clinics Prevalence Mortality Follow-up Study (LRCF) and Coronary Primary Prevention Trial (CPPT), and Multiple Risk Factor Intervention Trial (MRFIT). In CPPT and MRFIT (both randomized trials in middle-age high-risk men), only the control groups were analyzed. A 1-mg/dl (0.026 mM) increment in HDLC was associated with a significant coronary heart disease risk decrement of 2% in men (FHS, CPPT, and MRFIT) and 3% in women (FHS). In LRCF, where only fatal outcomes were documented, a 1-mg/dl increment in HDLC was associated with significant 3.7% (men) and 4.7% (women) decrements in cardiovascular disease mortality rates. The 95% confidence intervals for these decrements in coronary heart and cardiovascular disease risk in the four studies overlapped considerably, and all contained the range 1.9-2.9%. HDLC levels were essentially unrelated to non-cardiovascular disease mortality. When differences in analytic methodology were eliminated, a consistent inverse relation of HDLC levels and coronary heart disease event rates was apparent in BRHS as well as in the four American studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.79.1.8

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Self-citation
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A SIMPLIFIED METHOD FOR THE ESTIMATION OF TOTAL CHOLESTEROL IN SERUM AND DEMONSTRATION OF ITS SPECIFICITY
Abell, L. L., Levy, B. B., Brodie, B. B., & Kendall, F. E. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50907-3 · Cited by 3,085
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Self-citation
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts
Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212

Flagged first, then by citations

Show all 27 references

Research works printed but not linked: 8

Miller NE, Forde OH, Thelle DS, Mjos OD: The Tromso Heart Study: High-density lipoprotein and coronary heart disease: A prospective case-control study. Lancet 1977; 1:965-970
Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA (for the Lipid Research Clinics Program): High-density lipoprotein cholesterol and coronary heart disease in hyper- cholesterolemic men: The Lipid Research Clinics Coronary Primary Prevention Trial. Circulation 1986;74:1217-1225
The Lipid Research Clinics Program Epidemiology Commit- tee: Plasma Lipid Distribution in Selected North American Populations: The Lipid Research Clinics Program Preva- lence Study. Circulation 1979;60:427-439
The Lipid Research Clinics Program: The Coronary Primary Prevention Trial: Design and implementation. J Chronic Dis 1979;32:609-631
The Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduc- tion in incidence of coronary heart disease. JA1M 1984; 251:351-364
The Multiple Risk Factor Intervention Trial Group: Statisti- cal design considerations in the NHLBI Multiple Risk Fac- tor Intervention Trial (MRFIT). J Chronic Dis 1977; 30:261-275
Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. JAMA 1982;248:1465-1477
Shestov DB: Results of four years of follow-up of USSR populations, in USA-USSR First Lipoprotein Symposium. US Department of Health and Human Services Publication (NIH) 83-1966, Bethesda, Md, 1982, pp 391-407

Sorted by citations

Items 201–300 of 1,007

Current and future treatment of hyperlipidemia: the role of statins.
Farnier, M., & Davignon, J. (1998) · American Journal of Cardiology · doi:10.1016/s0002-9149(98)00423-8 · Cited by 196
Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study
Miller, M., Seidler, A., Moalemi, A., & Pearson, T. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00083-7 · Cited by 193
Effects of Dietary Flavonoids on Reverse Cholesterol Transport, HDL Metabolism, and HDL function
Millar, C. L., Duclos, Q., & Blesso, C. N. (2017) · Advances in Nutrition · doi:10.3945/an.116.014050 · Cited by 208
Commentary: Understanding the epidemiology of overweight and obesity—a real global public health concern
Kim, S.-W., & Popkin, B. M. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi255 · Cited by 198
Effects of aerobic exercise on lipids and lipoproteins in adults with type 2 diabetes: a meta-analysis of randomized-controlled trials
Kelley, G. A., & Kelley, K. S. (2007) · Public Health · doi:10.1016/j.puhe.2007.02.014 · Cited by 184
Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL
Cheung, M. C., Zhao, X.-Q., Chait, A., Albers, J. J., & Brown, B. G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0801.095151 · Cited by 192
Echo-Lucency of Computerized Ultrasound Images of Carotid Atherosclerotic Plaques Are Associated With Increased Levels of Triglyceride-Rich Lipoproteins as Well as Increased Plaque Lipid Content
Grønholdt, M.-L. M., Nordestgaard, B. G., Wiebe, B. M., Wilhjelm, J. E., & Sillesen, H. H. (1998) · Circulation · doi:10.1161/01.cir.97.1.34 · Cited by 188
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
Hata, Y., Mabuchi, H., Saitō, Y., Itakura, H., Egusa, G., Ito, H., Teramoto, T., Tsushima, M., Tada, N., Oikawa, S., et al. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.1 · Cited by 188
ATP-binding cassette transporter AI and its role in HDL formation
Lee, J., & Parks, J. S. (2005) · Current Opinion in Lipidology · doi:10.1097/00041433-200502000-00005 · Cited by 187
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases
The Emerging Risk Factors Collaboration (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9165-7 · Cited by 192
LDL‐cholesterol versus HDL‐cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos
Badimón, L., & Vilahur, G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06480.x · Cited by 200
Effects of curcumin on HDL functionality
Ganjali, S., Blesso, C. N., Banach, M., Pirro, M., Majeed, M., & Sahebkar, A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.008 · Cited by 186
The Current State of Niacin in Cardiovascular Disease Prevention
Lavigne, P. M., & Karas, R. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.030 · Cited by 185
A cohort study of diabetic patients and diabetic foot ulceration patients in China
Jiang, Y., Wang, X., Lei, X., Fu, X., Xu, Z., Ran, X., Yan, L., Li, Q., Mo, Z., Yan, Z., et al. (2015) · Wound Repair and Regeneration · doi:10.1111/wrr.12263 · Cited by 185
Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content
Hjerpsted, J., Leedo, E., & Tholstrup, T. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.022426 · Cited by 186
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial
Nicholls, S. J., Andrews, J., Kastelein, J. J. P., Merkely, B. P., Nissen, S. E., Ray, K. K., Schwartz, G. G., Worthley, S. G., Keyserling, C., Dasseux, J., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2121 · Cited by 191
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials
Ferretti, G., Bacchetti, T., & Sahebkar, A. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.08.003 · Cited by 185
Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity
Pascot, A., Lemieux, I., Prud’homme, D., Tremblay, A., Nadeau, A., Couillard, C., Bergeron, J., Lamarche, B., & Després, J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31529-7 · Cited by 186
Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits.
Ameli, S., Hultgårdh‐Nilsson, A., Cercek, B., Shah, P. K., Forrester, J. S., Ageland, H., & Nilsson, J. (1994) · Circulation · doi:10.1161/01.cir.90.4.1935 · Cited by 184
Plasma LDL and HDL Cholesterol and Oxidized LDL Concentrations Are Altered in Normo- and Hypercholesterolemic Humans after Intake of Different Levels of Cocoa Powder
Baba, S., Natsume, M., Yasuda, A., Nakamura, Y., Tamura, T., Osakabe, N., Kanegae, M., & Kondo, K. N. (2007) · Journal of Nutrition · doi:10.1093/jn/137.6.1436 · Cited by 183
Thyroid function and prevalent and incident metabolic syndrome in older adults: the health, ageing and body composition study
Waring, A. C., Rodondi, N., Harrison, S. L., Kanaya, A. M., Simonsick, E. M., Miljkovic, I., Satterfield, S., Newman, A. B., Bauer, D. C., & for the Health, A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04328.x · Cited by 184
Carotid Atherosclerosis in Premenopausal and Postmenopausal Women and Its Association With Risk Factors Measured After Menopause
Sutton‐Tyrrell, K., Lassila, H. C., Meilahn, E. N., Bunker, C. H., Matthews, K. A., & Kuller, L. H. (1998) · Stroke · doi:10.1161/01.str.29.6.1116 · Cited by 181
High-Density Lipoproteins Protect Endothelial Cells from Tumor Necrosis Factor-α-Induced Apoptosis
Sugano, M., Tsuchida, K., & Makino, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2877 · Cited by 180
Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol
Marques, L. R., Diniz, T. A., Antunes, B. M., Rossi, F. E., Caperuto, É. C., Lira, F. S., & Gonçalves, D. C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00526 · Cited by 180
Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives
Chapman, M. J. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00156-4 · Cited by 181
Vitamin D May Not Improve Lipid Levels
Ponda, M. P., Huang, X., Odeh, M. A., Breslow, J. L., & Kaufman, H. W. (2012) · Circulation · doi:10.1161/circulationaha.111.077875 · Cited by 179
Marital status and quality in middle-aged women: Associations with levels and trajectories of cardiovascular risk factors.
Gallo, L. C., Troxel, W., Matthews, K. A., & Kuller, L. H. (2003) · Health Psychology · doi:10.1037/0278-6133.22.5.453 · Cited by 179
Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men.
Strandberg, T. E., Salomaa, V. V., Naukkarinen, V., Vanhanen, H. T., Sarna, S. J., & Miettinen, T. A. (1991) · PubMed · Cited by 179
Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular Benefit
McTaggart, F., & Jones, P. J. H. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6113-z · Cited by 186
Blood lipid response to 20 weeks of supervised exercise in a large biracial population: The HERITAGE family study
Leon, A. S., Rice, T., Mandel, S., Despres, J.-P., Bergeron, J., Gagnon, J., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80018-9 · Cited by 176
Severe Atherosclerosis and Hypoalphalipoproteinemia in the Staggerer Mouse, a Mutant of the Nuclear Receptor RORα
Mamontova, A., Séguret-Macé, S., Esposito, B., Chaniale, C., Bouly, M., Delhaye-Bouchaud, N., Luc, G., Staels, B., Duverger, N., Mariani, J., et al. (1998) · Circulation · doi:10.1161/01.cir.98.24.2738 · Cited by 172
The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH) trial
Aim-High Investigators (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.12.007 · Cited by 174
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial
Nicholls, S. J., Puri, R., Ballantyne, C. M., Jukema, J. W., Kastelein, J. J. P., Köenig, W., Wright, R. S., Kallend, D. G., Wijngaard, P. L. J., Borgman, M., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2112 · Cited by 178
Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice
Mertens, A. C., Verhamme, P. B., Bielicki, J. K., Phillips, M. C., Quarck, R. A., Verreth, W., Stengel, D., Ninio, E., Navab, M., Mackness, B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000056523.08033.9f · Cited by 171
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN
Puri, R., Libby, P., Nissen, S. E., Wolski, K., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R., Raichlen, J. S., Uno, K., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jet251 · Cited by 174
High-Density Lipoprotein Cholesterol and Mortality
Hamer, M., O’Donovan, G., & Stamatakis, E. A. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310587 · Cited by 171
Effect of a Nutritional and Behavioral Intervention on Energy-Reduced Mediterranean Diet Adherence Among Patients With Metabolic Syndrome
Sayón-Orea, C., Razquín, C., Bulló, M., Corella, D., Fitó, M., Romaguera, D., Vioqué, J., Alonso‐Gómez, Á. M., Wärnberǵ, J., Martínez, J. A., et al. (2019) · JAMA · doi:10.1001/jama.2019.14630 · Cited by 176
Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?
Lemieux, S., Despr�s, J.-P., Moorjani, S., Nadeau, A., riault, G. T., Prud’homme, D., Tremblay, A., Bouchard, C., & Lupien, P. J. (1994) · Diabetologia · doi:10.1007/bf00404332 · Cited by 174
Formation of Dysfunctional High-Density Lipoprotein by Myeloperoxidase
Nicholls, S. J., Zheng, L., & Hazen, S. L. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.06.004 · Cited by 171
Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits
Morehouse, L. A., Sugarman, E. D., Bourassa, P.-A. K., Sand, T. M., Zimetti, F., Gao, F., Rothblat, G. H., & Milici, A. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600332-jlr200 · Cited by 173
HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis
Tsompanidi, E. M., Brinkmeier, M. S., Fotiadou, E. H., Giakoumi, S. M., & Kypreos, K. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.034 · Cited by 171
The role of fibric acids in atherosclerosis
Fruchart, J., Staels, B., & Duriez, P. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0015-x · Cited by 171
Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study
Childs, C. E., Röytiö, H., Alhoniemi, E. J., Fekete, A. A., Forssten, S. D., Hudjec, N., Lim, Y. N., Steger, C. J., Yaqoob, P., Tuohy, K. M., et al. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513004261 · Cited by 177
Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study
Ellison, R. C., Zhang, Y., Qureshi, M. M., Knox, S. S., Arnett, D. K., & Province, M. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.033 · Cited by 165
Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease
Barter, P. J., & Kastelein, J. J. P. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.042 · Cited by 171
Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists
Fitridge, R., & Thompson, M. M. (2011) · Cited by 168
1H NMR spectroscopy of human blood plasma
Ala‐Korpela, M. (1995) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/0079-6565(95)01013-0 · Cited by 168
The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism
Clifton-Bligh, P. B., Baber, R., Fulcher, G., Nery, M.-L., & Moreton, T. (2001) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200107000-00007 · Cited by 166
Excess body weight. An under-recognized contributor to dyslipidemia in white American women
Denke, M. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.4.401 · Cited by 166
A Macadamia Nut-Rich Diet Reduces Total and LDL-Cholesterol in Mildly Hypercholesterolemic Men and Women
Griel, A. E., Cao, Y., Bagshaw, D., Cifelli, A. M., Holub, B. J., & Kris‐Etherton, P. M. (2008) · Journal of Nutrition · doi:10.1093/jn/138.4.761 · Cited by 165
Associations of Glycemic Index and Load With Coronary Heart Disease Events: A Systematic Review and Meta‐Analysis of Prospective Cohorts
Mirrahimi, A., de Souza, R. J., Chiavaroli, L., Sievenpiper, J. L., Beyene, J., Hanley, A. J., Augustin, L. S. A., Kendall, C. W. C., & Jenkins, D. J. A. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.000752 · Cited by 161
Baseline and On-Treatment High-Density Lipoprotein Cholesterol and the Risk of Cancer in Randomized Controlled Trials of Lipid-Altering Therapy
Jafri, H., Alsheikh-Ali, A. A. A., & Karas, R. H. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.069 · Cited by 160
Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
Laakso, M., & Lehto, S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00314-6 · Cited by 161
Dynamics of reverse cholesterol transport: protection against atherosclerosis
Sviridov, D., & Nestel, P. J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00677-3 · Cited by 161
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.
Cohen, J. C., Wang, Z., Grundy, S. M., STOESZ, M. R., & Guerra, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117603 · Cited by 158
Effects of natural honey consumption in diabetic patients: an 8-week randomized clinical trial
Bahrami, M., Ataie‐Jafari, A., Hosseini, S., Foruzanfar, M.-H., Rahmani, M., & Pajouhi, M. (2009) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637480801990389 · Cited by 160
Cardiovascular risk continuum: implications of insulin resistance and diabetes
Hsueh, W. A., & Law, R. E. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00205-8 · Cited by 158
Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women
Roo, G. W. D. V.-D., Stehouwer, C. D. A., Meijer, P., Mijatovic, V., Kluft, C., Kenemans, P., Cohen, F. J., Watts, S. D., & Netelenbos, J. C. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.2993 · Cited by 158
Dysfunctional HDL as a Diagnostic and Therapeutic Target
Smith, J. D. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179226 · Cited by 157
Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All‐Cause Mortality: Observations From the Framingham Study Over 35 Years
Duncan, M. S., Vasan, R. S., & Xanthakis, V. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011433 · Cited by 163
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Banach, M., Burchardt, P., Chlebus, K., Dobrowolski, P., Dudek, D., Dyrbuś, K., Gąsior, M., Jankowski, P., Jozwiak, J. J., Kłosiewicz−Latoszek, L., et al. (2021) · Archives of Medical Science · doi:10.5114/aoms/141941 · Cited by 168
Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease
Brewer, H. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00308-2 · Cited by 158
Egg Phospholipids and Cardiovascular Health
Blesso, C. N. (2015) · Nutrients · doi:10.3390/nu7042731 · Cited by 163
Dyslipidemia and cardiovascular risk: the importance of early prevention
Miller, M. J. (2009) · QJM · doi:10.1093/qjmed/hcp065 · Cited by 165
HIV infection and high density lipoprotein metabolism
Rose, H. M., Hoy, J., Woolley, I. J., Tchoua, U., Bukrinsky, M., Dart, A. M., & Sviridov, D. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.018 · Cited by 153
Epidemiology of Type 2 Diabetic Foot Problems and Predictive Factors for Amputation in China
Jiang, Y., Ran, X., Jia, L., Yang, C. H., Wang, P., Ma, J., Chen, B., Yu, Y., Feng, B., Chen, L., et al. (2015) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734614564867 · Cited by 153
Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials
Brown, B. G., Stukovsky, K. H., & Zhao, X.-Q. (2006) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32800ff750 · Cited by 155
Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
van Lennep, J. E. R., Westerveld, H. T., van Lennep, H. W. O. R., Zwinderman, A. H., Erkelens, D. W., & van der Wall, E. E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2408 · Cited by 152
Chapter 5 Biomarkers Related To Aging In Human Populations
Crimmins, E. M., Vasunilashorn, S. M., Kim, J. K., & Alley, D. E. (2008) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)00405-8 · Cited by 159
Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health.
Carleton, R. A., Dwyer, J. T., Finberg, L., Flora, J. D., Goodman, D. S., Grundy, S. M., Havas, S., Hunter, G., Kritchevsky, D., & Lauer, R. M. (1991) · Circulation · doi:10.1161/01.cir.83.6.2154 · Cited by 155
Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome?
Barter, P. J., & Rye, K. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.148817 · Cited by 151
Effect of prolonged exercise training without weight loss on high-density lipoprotein metabolism in overweight men
Thompson, P. D., Yurgalevitch, S. M., Flynn, M. M., Zmuda, J. M., Spannaus-Martin, D. J., Saritelli, A. L., Bausserman, L., & Herbert, P. N. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90305-x · Cited by 151
4-Hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent
Narender, T., Puri, A., ., S., Khaliq, T., Saxena, R., Bhatia, G., & Chandra, R. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.003 · Cited by 152
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy, D. J., & Yellon, D. M. (2008) · Heart · doi:10.1136/hrt.2007.125401 · Cited by 151
Effects of Berries Consumption on Cardiovascular Risk Factors: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials
Huang, H., Chen, G., Liao, D., Zhu, Y., & Xue, X. (2016) · Scientific Reports · doi:10.1038/srep23625 · Cited by 157
Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH–JAPAN study
Hirata, A., Sugiyama, D., Watanabe, M., Tamakoshi, A., Iso, H., Kotani, K., Kiyama, M., Yamada, M., Ishikawa, S., Murakami, Y., et al. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.01.014 · Cited by 150
Changes in the age dependence of mortality and disability: Cohort and other determinants
Mantón, K. G., Stallard, E., & Corder, L. S. (1997) · Demography · doi:10.2307/2061664 · Cited by 149
Heterozygous Lipoprotein Lipase Deficiency: Frequency in the General Population, Effect on Plasma Lipid Levels, and Risk of Ischemic Heart Disease
Nordestgaard, B. G., Abildgaard, S., Wittrup, H. H., Steffensen, R., Jensen, G., & Tybjærg-Hansen, A. (1997) · Circulation · doi:10.1161/01.cir.96.6.1737 · Cited by 146
Gender differences in lipoprotein metabolism and dietary response: Basis in hormonal differences and implications for cardiovascular disease
Knopp, R. H., Paramsothy, P., Retzlaff, B. M., Fish, B., Walden, C., Dowdy, A., Tsunehara, C., Aikawa, K., & Cheung, M. C. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0065-6 · Cited by 148
HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy
Linton, M. F., Yancey, P. G., Tao, H., & Davies, S. S. (2023) · Circulation Research · doi:10.1161/circresaha.123.321563 · Cited by 159
Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility
Weng, W., & Breslow, J. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14788 · Cited by 148
Cholesteryl Ester Transfer Protein Taq I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency
Brousseau, M. E., O’Connor, J. J., Ordovás, J. M., Collins, D. E., Otvos, J. D., Massov, T., McNamara, J. R., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000024566.57589.2e · Cited by 149
Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy
Fang, B., Kovačević, Ž., Park, K. C., Kalinowski, D. S., Jansson, P. J., Lane, D. J. R., Sahni, S., & Richardson, D. R. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.11.002 · Cited by 151
Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease.
Pocock, S., Shaper, A. G., & Phillips, A. N. (1989) · BMJ · doi:10.1136/bmj.298.6679.998 · Cited by 147
Pleiotropic genes for metabolic syndrome and inflammation
Kraja, A. T., Chasman, D. I., North, K. E., Reiner, A. P., Yanek, L. R., Kilpeläinen, T. O., Smith, J. A., Dehghan, A., Dupuis, J., Johnson, A. D., et al. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.04.007 · Cited by 149
Diet composition and the metabolic syndrome: what is the optimal fat intake?
Grundy, S. M., Abate, N. I., & Chandalia, M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00988-3 · Cited by 146
Physical Activity and High Density Lipoprotein Cholesterol Levels
Kokkinos, P. F., & Fernhall, B. (1999) · Sports Medicine · doi:10.2165/00007256-199928050-00002 · Cited by 148
Prevention and Treatment of the Metabolic Syndrome
Daskalopoulou, S. S., Mikhailidis, D. P., & Elisaf, M. (2004) · Angiology · doi:10.1177/00033197040550i601 · Cited by 147
Mechanisms and Treatment of Dyslipidemia in Diabetes
Bahiru, E. M., Hsiao, R., Philipson, D. J., & Watson, K. E. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01455-w · Cited by 145
Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
Saarto, T., BLOMQVIST, C. P., Ehnholm, C., Taskinen, M., & Elomaa, I. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.429 · Cited by 145
Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease: An Individual Participant Data Meta-Analysis of 23 Studies in the Asia-Pacific Region
Huxley, R. R., Barzi, F., Lam, T. H., Czernichow, S., Fang, X., Welborn, T., Shaw, J., Ueshima, H., Zimmet, P., Jee, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.028373 · Cited by 144
Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups
Blasetto, J. W., Stein, E. A., Brown, W. V., Chitra, R., & Raza, A. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00003-1 · Cited by 143
Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action
Clark, R. W., Ruggeri, R. B., Cunningham, D., & Bamberger, M. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500349-jlr200 · Cited by 144
Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr−/−, ApoA-I−/− Mice
Wilhelm, A. J., Zabalawi, M., Owen, J. S., Shah, D., Grayson, J. M., Major, A. S., Bhat, S., Gibbs, D. P., Thomas, M. J., & Sorci‐Thomas, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134130 · Cited by 145
Cholesterol measures to identify and treat individuals at risk for coronary heart disease
Natarajan, S., Glick, H. A., Criqui, M. H., Horowitz, D., Lipsitz, S. R., & Kinosian, B. P. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(03)00092-8 · Cited by 142
Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice.
Busch, S. J., Barnhart, R. L., Martin, G. A., Fitzgerald, M. C., Yates, M. T., Mao, S. J., Thomas, C. E., & Jackson, R. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34018-8 · Cited by 139
Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan
Chen, C., Li, T., Chang, P.-C., Liu, C.-S., Lin, W., Wu, M., Li, C., Lai, M.-M., & Lin, C. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.018 · Cited by 141
Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
Higashi, Y. (2023) · Cells · doi:10.3390/cells12091293 · Cited by 163
Effects of the Menopause, Gender, and Estrogen Replacement Therapy on Vascular Nitric Oxide Activity
Majmudar, N. G., Robson, S. C., & Ford, G. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6530 · Cited by 140
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study
Erem, C., Hacıhasanoğlu, A., Değer, O., Koçak, M., & Topbaş, M. (2008) · Endocrine · doi:10.1007/s12020-008-9100-z · Cited by 139

Authors: Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A.
Affiliations: National Institutes of Health (US)
ORCID: Probstfield, J L
Neaton, J D
Knoke, J D
Jacobs, D R
Bangdiwala, S
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1989-01
Volume: 79
Issue: 1
Pages: 8-15
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.79.1.8
OpenAlex: W2077760013
Cited by: 3,162
References: 27
Citations by year: 2026: 35 · 2025: 41 · 2024: 62 · 2023: 69 · 2022: 90 · 2021: 90 · 2020: 90 · 2019: 84 · 2018: 96 · 2017: 87 · 2016: 81 · 2015: 125 · 2014: 137 · 2013: 125 · 2012: 129
FWCI: 61.95
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hv012156-034)
National Heart, Lung, and Blood Institute (N01-HV32961, N01-HV 12156, N01-HV 12159)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: HDL cholesterol, coronary artery disease, cardiovascular mortality, inverse association, Framingham Heart Study, Multiple Risk Factor Intervention Trial, British Regional Heart Study, cardiovascular risk, sex differences
MeSH terms: Adult, Aged, Cardiovascular Diseases, Clinical Trials as Topic, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Prospective Studies, Regression Analysis, Risk Factors, Sex Factors, Statistics as Topic, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks